Company Filing History:
Years Active: 2011-2014
Title: Eric Stanley Muise: Innovator in Target Molecule Characterization
Introduction
Eric Stanley Muise is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the characterization of agonists and partial agonists of target molecules. With a total of 2 patents, his work has implications for medical research and therapeutic development.
Latest Patents
Muise's latest patents focus on innovative methods for characterizing agonists and partial agonists of target molecules. One aspect of his invention provides methods to determine whether an agent behaves more like a partial agonist than a full agonist of the same target molecule. Additionally, he has developed methods to select candidate compounds that may reduce blood plasma glucose concentration in mammals. These advancements are crucial for understanding drug interactions and developing new treatments.
Career Highlights
Eric Muise is currently employed at Merck Sharp & Dohme Corp., a leading pharmaceutical company. His role involves extensive research and development in the field of pharmacology. His contributions have been instrumental in advancing the understanding of how different compounds interact with biological targets.
Collaborations
Throughout his career, Muise has collaborated with talented individuals such as Yejun Tan and Hongyue Dai. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Eric Stanley Muise is a distinguished inventor whose work in the characterization of target molecules has the potential to impact medical science significantly. His patents and collaborations reflect his commitment to advancing biochemistry and pharmacology.